Clinically-guided models or foundation models? predicting cervical spondylotic myelopathy from electronic health records - Scorecard - MDSpire

Clinically-guided models or foundation models? predicting cervical spondylotic myelopathy from electronic health records

  • By

  • Salim Yakdan

  • Ben Warner

  • Zoher Ghogawala

  • Wilson Z. Ray

  • Mohamad Bydon

  • Michael P. Steinmetz

  • Richard T. Griffey

  • Randi Foraker

  • Adam Wilcox

  • Chenyang Lu

  • Jacob K. Greenberg

  • January 20, 2026

  • 0 min

Share

Clinical Scorecard: Comparing Clinically-Guided and Foundation Models for Predicting Cervical Spondylotic Myelopathy Using Electronic Health Records

At a Glance

CategoryDetail
ConditionCervical spondylotic myelopathy (CSM), a progressive spinal cord dysfunction caused by degenerative cervical stenosis
Key MechanismsDegenerative spinal changes causing cervical stenosis leading to neurological deficits such as impaired hand dexterity, gait disturbances, bladder/bowel dysfunction, and paralysis
Target PopulationOlder adults, particularly those over 60 years with spinal cord compression or neurological symptoms
Care SettingPrimary care, spine surgery practices, and healthcare systems utilizing electronic health records (EHRs)

Key Highlights

  • CSM diagnosis is often delayed 2 to 6 years after symptom onset, leading to worse outcomes.
  • Approximately one-third of asymptomatic individuals over 60 show spinal cord compression; about 22% become symptomatic.
  • Machine learning models using large-scale EHR data can predict CSM incidence up to 30 months before diagnosis, enabling earlier intervention.

Guideline-Based Recommendations

Diagnosis

  • Early recognition of clinical features such as unsteady gait and neurological deficits is critical.
  • Use of targeted neurological assessments and advanced imaging is recommended for suspected cases.
  • Screening programs are currently limited to spine surgery practices due to practical constraints.

Management

  • Timely intervention is essential to prevent irreversible neurological damage.
  • Clinical decision support systems leveraging EHR-based prediction models may guide earlier diagnostic workups.

Monitoring & Follow-up

  • Monitor patients with risk factors or early symptoms closely to detect progression.
  • Utilize EHR data to track clinical encounters and relevant diagnostic studies over time.

Risks

  • Delayed diagnosis is associated with significant disease progression and poorer outcomes.
  • Limited awareness among primary care providers contributes to diagnostic delays.

Patient & Prescribing Data

Over 1.9 million patients across multiple datasets including 47,306 with CSM and over 1.9 million controls

Machine learning models demonstrated 5- to 7-fold improvement in predictive performance over non-informative classifiers, supporting their potential utility in early detection and management strategies.

Clinical Best Practices

  • Increase awareness of CSM clinical features among primary care providers to reduce diagnostic delays.
  • Incorporate machine learning-based clinical decision support tools into EHR systems to identify high-risk patients.
  • Prioritize early neurological assessments and imaging within 6 to 30 months of predicted risk to optimize outcomes.

References

Original Source(s)

Related Content